Century Therapeutics (IPSC) Asset Utilization Ratio (2022 - 2025)
Century Therapeutics' (IPSC) quarterly Asset Utilization Ratio came in at 0.47 in Q4 2025, up 2523.4% year-on-year from 0.02 in Q4 2024, and up 8.86% on a QoQ basis from 0.43 in Q3 2025.
Century Therapeutics (IPSC) Asset Utilization Ratio (2022 - 2025) Analysis & Trends
Century Therapeutics (IPSC) has 4 years of Asset Utilization Ratio data on file, last reported at 0.47 in Q4 2025.
- On a quarterly basis, Asset Utilization Ratio rose 2523.4% year-over-year to 0.47 in Q4 2025; TTM through Dec 2025 was 0.47, a 2523.4% increase from a year earlier, with the FY2025 full-year figure at 0.38, up 1950.15% from the prior year.
- Asset Utilization Ratio for Q4 2025 stood at 0.47, up from 0.43 in the prior quarter.
- Over the last five years, Asset Utilization Ratio for IPSC reached as high as 0.47 in Q4 2025 and fell as low as 0.0 in Q1 2024.
- Historically, Asset Utilization Ratio has averaged 0.13 across 4 years, with a median of 0.01 in 2023.
- Across the five-year window, Asset Utilization Ratio tumbled 68.93% in 2024 and surged 8793.05% in 2025, its largest moves.
- Year by year, Asset Utilization Ratio stood at 0.01 in 2022, then slumped by 43.4% to 0.01 in 2023, then surged by 201.38% to 0.02 in 2024, then soared by 2523.4% to 0.47 in 2025.
- Per Business Quant data, the three most recent Asset Utilization Ratio figures were 0.47 in Q4 2025, 0.43 in Q3 2025, and 0.38 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.69 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 0.47 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 0.37 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Century Therapeutics | 406.30 Mn | 271.49 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.47 |
| Sep 30, 2025 | 0.43 |
| Jun 30, 2025 | 0.38 |
| Mar 31, 2025 | 0.34 |
| Dec 31, 2024 | 0.02 |
| Sep 30, 2024 | 0.01 |
| Jun 30, 2024 | 0.01 |
| Mar 31, 2024 | 0.00 |
| Dec 31, 2023 | 0.01 |
| Sep 30, 2023 | 0.01 |
| Jun 30, 2023 | 0.01 |
| Mar 31, 2023 | 0.01 |
| Dec 31, 2022 | 0.01 |